- Home
- SYRE vs CSGS Comparison
SYRE vs CSGS Comparison
Compare SYRE & CSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- CSGS
- Stock Information
- Founded
- SYRE 2013
- CSGS 1994
- Country
- SYRE United States
- CSGS United States
- Employees
- SYRE 60
- CSGS N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- CSGS EDP Services
- Sector
- SYRE Health Care
- CSGS Technology
- Exchange
- SYRE Nasdaq
- CSGS Nasdaq
- Market Cap
- SYRE 1.3B
- CSGS 1.5B
- IPO Year
- SYRE 2016
- CSGS 1996
- Fundamental
- Price
- SYRE $21.29
- CSGS $64.01
- Analyst Decision
- SYRE Strong Buy
- CSGS Buy
- Analyst Count
- SYRE 8
- CSGS 7
- Target Price
- SYRE $51.50
- CSGS $69.29
- AVG Volume (30 Days)
- SYRE 550.7K
- CSGS 337.8K
- Earning Date
- SYRE 03-03-2025
- CSGS 02-05-2025
- Dividend Yield
- SYRE N/A
- CSGS 1.98%
- EPS Growth
- SYRE N/A
- CSGS 37.73
- EPS
- SYRE N/A
- CSGS 3.03
- Revenue
- SYRE N/A
- CSGS $1,197,248,000.00
- Revenue This Year
- SYRE $168.62
- CSGS $4.16
- Revenue Next Year
- SYRE $47.61
- CSGS $3.37
- P/E Ratio
- SYRE N/A
- CSGS $21.31
- Revenue Growth
- SYRE N/A
- CSGS 2.39
- 52 Week Low
- SYRE $20.13
- CSGS $39.56
- 52 Week High
- SYRE $47.97
- CSGS $65.53
- Technical
- Relative Strength Index (RSI)
- SYRE 40.66
- CSGS 69.76
- Support Level
- SYRE $21.61
- CSGS $63.06
- Resistance Level
- SYRE $23.04
- CSGS $65.53
- Average True Range (ATR)
- SYRE 1.43
- CSGS 1.57
- MACD
- SYRE -0.03
- CSGS -0.02
- Stochastic Oscillator
- SYRE 22.03
- CSGS 80.95
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).